Company: FTII
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001641172-25-011790
Chunk: 9

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Item 8
Chunk 9
---
 and expects that the Company’s securities will be quoted on the over-the-counter market. The Company intends to apply to list the securities of post-business-combination Company on The Nasdaq Capital Market
upon Closing of the Business Combination. However, there is no guarantee that the listing application will be successful.

The material adverse
consequences of having our securities quoted on the OTC Pink Mark includes our ability to consummate the Business Combination; reduced
liquidity for our securities; a limited availability of market quotations for our securities; a determination that our shares of
common stock are a “penny stock” which will require brokers trading in our shares of common stock to adhere to more
stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; a
decreased ability to issue additional securities or obtain additional financing in the future; a limited amount of news and analyst
coverage; and becoming a less attractive merger partner for a target company or business. We also note that if Nasdaq delists the
Company’s securities from trading on its exchange and the Company is not able to list its securities on another national
securities exchange, it may affect the Company’s ability to consummate its planned Business Combination with Longevity.

In addition, the Company’s
ability to consummate a transaction may be dependent on the ability to raise equity or debt financing which may be impacted by these events,
including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms
acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the
Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable.
The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2 - Summary of Significant Accounting
Policies

Basis of Presentation

The accompanying unaudited
condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of
America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of
Regulation S-X of the SEC. Certain information or footnote disclosures normally included
in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the
SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary